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Abstract.  Heparan sulfate proteoglycans (HSPGs) are 
found on the surface of all adherent cells and partici- 
pate in the binding of growth factors, extraceUular ma- 
trix glycoproteins, cell adhesion molecules, and pro- 
teases and antiproteases.  We report here the cloning 
and pattern of expression of cerebroglycan, a glycosyl- 
phosphatidylinositol  (GPI)-anchored HSPG that is 
found in the developing rat brain (previously referred to 
as HSPG M13; Herndon,  M.  E.,  and A.  D. Lander. 
1990.  Neuron.  4:949-961),  The cerebroglycan core 
protein has a predicted molecular mass of 58.6 kD and 
five potential heparan  sulfate attachment sites.  To- 
gether with glypican (David, G., V.  Lodes, B.  De- 
cock, P. Marynen, J.-J.  Cassiman,  and H.  Van den 
Berghe.  1990.  J.  Cell Biol.  111:3165-3176),  it defines 
a  family of integral membrane HSPGs characterized 
by GPI linkage and conserved structural motifs, in- 
cluding a pattern of 14 cysteine residues that is abso- 
lutely conserved.  Unlike other known integral mem- 
brane HSPGs, including glypican and members of the 
syndecan family of transmembrane proteoglycans, 
cerebroglycan is expressed in only one tissue: the ner- 
vous system. In situ hybridization experiments at sev- 
eral developmental stages strongly suggest that 
cerebroglycan message is widely and transiently ex- 
pressed by immature neurons,  appearing around the 
time of final  mitosis and disappearing after cell migra- 
tion and axon outgrowth have been completed. These 
results suggest that cerebroglycan may fulfill a  func- 
tion related to the motile behaviors of developing 
neurons. 
p 
ROTEOGLYCANS (PGs)~-proteins  that  bear  glycos- 
aminoglycan  (GAG) side chains-are  abundant  sur- 
face components of all adherent cells, and are thought 
to play important roles in cell growth,  morphogenesis  and 
cancer (7, 23, 57). Most commonly,  cell-surface PGs bear 
GAG chains of the heparan sulfate (HS) class and, because 
of this, have the potential to interact with many extracellular 
heparin-binding  proteins,  including  extracellular  matrix 
molecules,  cell-cell adhesion  molecules,  cell-surface en- 
zymes, and growth factors (35, 43).  It has been proposed 
that cell-surface HSPGs act as "co-receptors"  for such pro- 
teins, functioning to bring them together with more conven- 
tional molecules (e.g., signal-transducing  receptors) on the 
cell surface (7). Strong evidence for this model comes from 
studies  of the interaction  of basic fibroblast  growth  factor 
with one of its tyrosine kinase receptors, an interaction  that 
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1. Abbreviations  used in this paper:  GAG, glycosaminoglycan;  GAPDH, 
glyceraldehyde-phosphate  dehydrogenase; GPI, glycosylphosphatidylinosi- 
tol; HS, heparan sulfate;  PG, proteoglyeans. 
fails to occur in the absence of HS (36, 54, 78). Additional 
evidence has also come from studies of cell-surface protease 
inhibition by heparin-binding  anti-proteases  (17, 49), homo- 
philic  cell adhesion  mediated by the neural  cell  adhesion 
molecule NCAM (16, 55), and integrin-mediated cell-matrix 
interaction  (44, 75). 
The co-receptor model provides a useful framework within 
which to understand the general  functions  of HSPGs, but 
leaves open the question of whether specific functions  are 
associated with individual molecular species of HSPG. Cur- 
rently, five distinct polypeptides are known to be major car- 
riers of HS on mammalian cells. Four of these are transmem- 
brane proteins,  and form a gene family, the syndecans,  on 
the basis of strong  evolutionary  conservation  in their cyto- 
plasmic and transmembrane domains (7). The fifth is a gly- 
cosylphosphatidylinositol  (GPI)-anchored  protein known as 
glypican  (19). The  expression  of these PG core proteins 
varies dramatically  from tissue to tissue,  especially during 
the course of development  (7). Tissue-specific and develop- 
mental variation  also occurs in the structure of the HS that 
is found on these core proteins,  and such variation can give 
rise to substantial differences in the binding properties of in- 
tact PGs (49, 51, 58, 62, 63). Taken together,  the data sug- 
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carry out particular  functions. 
To explore this possibility, we have chosen to focus on the 
developing mammalian  nervous  system,  a tissue in which 
heparin-binding  molecules  mediate  numerous  cell-cell, 
cell-matrix,  and cell-growth factor interactions (42), and in 
which developmental processes occur with precise timing 
and anatomical  localization.  Previously,  we demonstrated 
that '~25 PG core proteins can be detected in the developing 
and adult rat brain (30). Of these, three species exhibited de- 
tergent partitioning  properties indicative of integral  mem- 
brane  proteins.  These  three  molecules,  all  of which  are 
HSPGs, are thus likely to represent the major cell surface 
PGs of the central nervous system. One of these ("M7; ref. 
30) is indistinguishable in biochemical properties and timing 
of expression from a member of the syndecan family, N-syn- 
decan,  or  syndecan  III,  which  is  expressed  in  perinatal 
brain,  peripheral  glia,  developing limbs, and other tissues 
(11, 28).  The second ("M12") is the GPI-anchored  HSPG 
glypican  (46).  The  third  species  ("M13")  is  also  a  GPI- 
anchored HSPG, and could be isolated from the developing 
brain,  but not from adult (30). 
We report here on studies that identify the M13 core as a 
novel membrane protein.  We confirm that it is expressed 
only during development and demonstrate that, unlike other 
PGs, M13 is restricted in expression to a single tissue-the 
nervous system. Moreover, although this PG is widely ex- 
pressed in many regions of the developing nervous system, 
the data suggest that expression is associated with neurons 
and is closely linked, in each region, to the time period when 
postmitotic neurons undergo migration and axon outgrowth, 
their major morphogenetic movements. The deduced amino 
acid sequence of this PG, which we call cerebroglycan, indi- 
cates that it, together with glypican, defines a new family of 
cell-surface HSPGs, the GPI-anchored  PGs.  Interestingly, 
the core proteins in this family exhibit an unexpectedly high 
degree of structural  homology, raising  the possibility that 
these molecules have evolved for more specialized functions 
than simply to be the passive bearers of GAG chains. 
Materials and Methods 
Materials 
Heparitinase was purified from Flavobacterium  heparinum by hydroxyapa- 
tite and phosphocellulose chromatography (45). The GAPDH eDNA clone 
was the generous gift of Dr. Timothy Hayes (National  Institutes of Health 
[NIH], Bethesda, MD). All restriction enzymes were from New England 
Biolabs (Beverly, MA). Chondroitinase  ABC, Triton X-100, NEM (N-ethyl- 
maleimide), pepstatin A, and PMSF, Hoechst 33258 dye (bisbenzimide), 
and PVP-40  (polyvinyl pyrrolidone) were obtained from Sigma Chemical 
Co. (St. Louis, MO). Trypsin, RNAse A, CHAPS (3-[(3 Cholamidopropyl) 
dimethyl-ammonio]-l-propanesulfonate),  and yeast RNA were from Boeh- 
ringer Mannheim Corp.  (Indianapolis,  IN). RNA and DNA ladders were 
from GIBCO BRL (Gaithersburg, MD). Nitrocellulose was from Schleicher 
and SchueU (Keene, NH). DEAE-Sephacel, dextran sulfate, salmon sperm 
DNA,  and ~  DNA polymerase were  from Pharmacia Fine Chemicals 
(Piscataway, NJ). Fornmmide was from Fluka (Buchs, Switzerland).  ~2p_ 
labeled dCTP and a35S-iabeled  UTP were  from DuPont NEN  (Boston, 
MA). All other reagents  were from Mallinckrodt (Paris,  KY),  except as 
noted. 
Purification and Microsequencing  of  HSPG M13 
Detergent extracts of a crude membrane fraction of neonatal (P0) Sprague- 
Dawley rat brains were prepared (30) and stored at -800C. Extracts from 
a total of 46.4 g (wet weight) of brain were used to purify PGs by anion 
exchange chromatography on DEAE-Sephacel (30). At this point, 0.3/zCi 
of t25I-labeled,  membrane-associated PGs, purified and radiolabeled  as 
previously  described (30),  was added to the PG pool as a tracer. 
Centriprep-10 tubes (Amicon Corp., Beverly, MA) were used to concen- 
trate the eluate and exchange the elution buffer for 50 mM Tris-HCl, pH 
8.0, 0.15 M NaCl, 0.1% Triton X-100. The sample was then treated with 
Chondroitinase ABC (0.09 U/ml) in the presence of 1 mM EDTA, 1/~g/ml 
pepstatin, and 0.4 mM PMSF for 2 h at 37°C, and loaded immediately onto 
a DEAE-Sephacel column (0.2 ml packed volume), equilibrated in 50 mM 
Tris-HCl,  pH  8.0, 0.15 M  NaCI,  0.1% Triton X-100. The column was 
washed successively  with 0.2 M NaC1, 100 mM sodium acetate, pH 3.5, 
0.1% Triton X-100; 0.1 M Tris-HCl, pH 8.0, 0.1% Triton X-100; 50 mM 
Tris-HC1, pH 8.0, 0.1% Triton X-100; and 25 mM ammonium acetate, pH 
7.0, 0.1% Triton X-100. An HSPG-enriched fraction was eluted with a 20-ml 
gradient of NaC1 from 0.15 to 0.75 M, in 25 mM ammonium acetate, pH 
7.0, and 0.1% Triton X-100. All radioactive fractions eluted by ~,0.3 M NaCI 
were pooled. In this manner, approximately  80 ~tg of HSPG were recovered 
(as determined by amino acid analysis). 
A Centricon-10 (Amicon Corp.) tube was used to concentrate the pooled 
sample and exchange the buffer to 50 mM NaC1, 25 mM ammonium ace- 
tate, 0.1% Triton X-100. The sample was made 25 mM in Tris-HC1 (pH 7.1 
at 37"C), and protease inhibitors added along with heparitinase to a final 
concentration of 9 tzg/ml. The HSPG sample was digested for 3 h at 37°C, 
concentrated in a Centricon-10  tube and loaded to a 9% SDS-PAGE gel. 
A control digest of identical composition but with no HSPGs was loaded 
in an adjacent lane of the gel. After electrophoresis,  the gel was electroblot- 
ted overnight at 25 V and 4°C to nitrocellulose in 25 mM Tris-HCl, pH 
8.3, 20 % (vol/vol) ethanol, 0.005 % SDS. Bands were visualized by staining 
with Amido Black (64), and the band corresponding to HSPG MI3 was ex- 
cised, as was a corresponding region from the control lane. 
The nitrocellulose-bound HSPG M13 was blocked with PVP-40 (0.5% 
in 100 mM acetic acid at 37"C for 30 rain) and then digested with trypsin 
for 18 h at 37°C in 100 mM ammonium carbonate/acetonitrile  (95:5 by vol- 
ume) (68).  Released  digestion  products were analyzed by reverse phase 
HPLC on a Hewlett Packard model 1090L HPLC equipped with a "~jdac 
21gl'P52 C18 column (Vydac, Hesperia, CA), and multiple peaks of absor- 
bance at 210 um were collected and subjected to microsequencing by auto- 
mated Edman degradation. 
PCR Amplification of  an HSPG-M13  cDNA 
Degenerate PCR primers were designed based on the sequence of poptide 
M13-22 (see Results and Table I). The sequences of the primers were 22L: 
5'-GGCC'IL-'TAF_O,  fUC)ATGC~(r/C)GA(UC)GCNGA-3, and 22R: 5'-GCG- 
CGGGCCCCT(GIA)TCNGC(G/A)TA(C/T)TG(C/T)TG 3'. PCR reactions 
were performed using 25 pmol of each PCR primer, 2 ~g of PO rat brain 
cDNA as template,  80 #M of each dNTP, and 2 U ofTaq polymerase.  The 
reaction profile was denature at 95"C for 60 s, anneal at 50"C for 90 s, and 
extend for 90 s at 72°C. 
Library Construction and Screening 
P0 rat brain polyA-enriched  RNA was prepared by fractionation on oligo 
dT cellulose using a Fast Track mRNA isolation kit (Invitrogen,  San Diego, 
CA).  cDNA was synthesized  from 5 t~g of poly(A)  + RNA using an oligo 
dT primer with the ZAP eDNA synthesis kit (Stratagene,  La JoUa, CA). 
The resulting eDNA was ligated  into EcoRI-XhoI digested  and dephos- 
phorylated Uni-ZAP XR vector arms (Stratagene) and packaged for plating 
(Giga Pack Gold II; Stratagene).  The library was amplified once before plat- 
ing on XL1-Blue host cells. The library was screened with a probe generated 
by a PCR reaction (as described above),  which included ot32P-dATE 
A primer-extended library was synthesized from 5/~g of polyA~entiched 
RNA (prepared as described above)  and 120 pmol of primer M13A-165 
(based on the sequence of eDNA MI3-A, see Results) using a Timesaver 
eDNA synthesis  kit (Pharmacia Fine Chemicals). The resulting eDNA, 
ligatnd to EcoRl adaptors,  was cloned into EcoRI-digested,  depbosphory- 
lated )~-gtl0 arms (Stratagene),  packaged (Giga Pack Gold II; Stratagene), 
and plated on NM514 host cells for screening with a probe generated from 
the 100 bp BgllI fragmem of M13-A (see Results) by random-primer label- 
ing (70200 Random Primed DNA Labeling Kit; United States Biochemical 
Corp., Cleveland,  OH). 
DNA Sequencing 
Gel purifiad  fragments were subeloned into pBluescript SK- (Stratagene) 
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termination method using a modified T7 DNA polymerase (Sequenase kit 
2.0; United States Biochemical Corp.). T3, T7, and M13 (-40) primers, as 
well as custom made primers, were used in reactions with denatured, super- 
coiled plasmids. All sequences were determined with both dGTP and dlTP. 
Table I.  HSPG M13 Peptide Sequence 
Peptide  Sequence 
M13-9 
Southern Blot Analysis 
Rat genomic DNA was prepared from Sprague-Dawley rat thymocytes ac-  M 13-10 
cording to Sambrook et al. (60), and stored at 4"C under ethanol. 20 t~g 
of DNA, digested to completion with HindIII, KpnI, or XhoI, was electro- 
phoresed and blotted to nitrocellulose according to Sambrook et al. (60). 
Prehybridization,  hybridization,  and  washing,  were  done  according  to  M13-21 
Church and Gilbert (14). The filter was autoradiographed with XAR-5 film 
(Eastman Kodak Co., Rochester, NY). 
Northern Blot Analysis 
Total RNA was isolated by guanidinium isothiocyanate extraction (13). 20 
#g of total RNA from embryonic day 18 (El8), P0, and adult rat brain was 
used for the Northern analysis, performed according to Sambrook et al. 
(60),  except that yeast RNA (200/zg/ml) and salmon sperm DNA (100 
/~g/ml) were included in the hybridization buffer.  Filters were exposed to 
Kodak  XAR-5  film or  imaged  with  a  phosphorimager (Molecular  Dy- 
namics, Inc., Sunnyvale, CA). The blot was re-probed for glyceraldehyde- 
phosphate dehydrogenase (GAPDH) mRNA to normalize for different load- 
ing and transfer etliciences between the lanes. 
In Situ Hybridization 
Freshly dissected rat embryos were quick-frozen in isopentane on dry ice 
and  stored at  -80°C.  Before sectioning, samples were equilibrated to 
-200C and embedded in OCT medium. 12-20-/zm cryostat sections were 
collected on gelatin-subbed slides or on Probe-On Plus slides (Fisher Bio- 
tech; Pittsburgh, PA) and stored at  -80°C with desiccant. Sections were 
equilibrated to room temperature, fixed in 4% paraformaldehyde in PBS at 
room temperature for 5 min, and washed twice in 2 x  SSC. Prehybridization 
treatments, hybridization, and post-hybridization washes were performed 
according to Simmons et al.  (67), except that the proteinase K step was 
omitted.  After hybridization, sections were exposed to hyperfilm/~max 
(Amersham Corp., Arlington Heights, IL) for 5-7 d at  -800C.  Selected 
sections were dipped in Kodak NTB-2 liquid emulsion that had been diluted 
1:1 in ddH20, and exposed for 12-21 days at  -80°C. Developed sections 
were stained in Hoechst 33258  (bisbenzimide) at  1 /~g/ml in ddH20 or 
cresyl violet (0.5 % in ddH20), and examined by fluorescence, bright field, 
and dark field illumination on a Zeiss Axiophot microscope, or a Nikon Di- 
aphot microscope. 
Results 
Molecular Cloning of HSPG MI3 
To establish the molecular identity of the M13 core protein, 
a PG-enriched fraction was prepared by DEAE-chromatog- 
raphy of a detergent extract of neonatal rat brain membranes 
(30).  The PG fraction was depleted of chondroitin sulfate 
PGs by treatment with chondroitinase ABC and refractiona- 
tion on DEAE-Sephacel. After heparitinase digestion, sepa- 
ration by SDS-PAGE,  and electroblotting to nitrocellulose, 
Amido Black staining revealed two major species. On the ba- 
sis of the previously characterized molecular weights of neo- 
natal rat brain membrane HSPG cores (30) one species was 
identified as HSPG M13, and the other as M12. Both bands 
were excised from the membrane and separately digested in 
situ with trypsin. The peptides released were separated by 
HPLC chromatography and selected peaks chosen for amino 
acid sequencing. 
The data obtained from HSPG M12  indicated that this 
molecule is the rat homologue of glypican (46).  In contrast, 
the four M13-derived peptides that were obtained (Table I) 
did not closely match any sequences in the NBRF database, 
M13-22 
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Selected M 13 tryptic peptides were subjected to automated Edman degradation 
after separation  by reverse-phase HPLC. Multiple letters indicate ambiguities 
in the sequence,  bold letters  indicate  the sequence which was later verified 
from the deduced amino acid sequence of M13 eDNA. 22L and 22R: bars indi- 
cate the unambiguous  amino acid sequence upon which the PCR primers 22L 
and 22R were based. 
but could be aligned with human glypican so as to reveal an 
overall sequence identity of 58 %. These data suggested that 
M13 might be a glypican-related molecule. 
To  facilitate further  characterization of HSPG  M13,  a 
eDNA was obtained from neonatal rat brain by PCR. Using 
primers 22L and 22R, which were based on unambiguous 
sequence at either end of peptide M13-22 (Table I), a major 
PCR product of ~80 bp was obtained. This product was sub- 
cloned and two independent clones were isolated and se- 
quenced. Both contained the sequences of primers 22L and 
22R, and the intervening sequences of both gave a deduced 
protein sequence which was an exact match for peptide M13- 
22 (data not shown), verifying that a genuine M13 eDNA had 
been amplified. 
To obtain a complete eDNA, a neonatal rat brain eDNA 
library was screened with a probe generated by PCR using 
ota2P-labeled dATP and primers 22L and 22R, with the gel- 
purified 80-bp M13 eDNA fragment as the template. Three 
positive plaques were identified out of 900,000 screened in 
the amplified library. All three were plaque purified, and all 
contained inserts of "~1,600 bp. Preliminary sequence data 
supported the conclusion that all three inserts were identical 
products of a single cloning event. Additional sequencing of 
this eDNA, referred to hereafter as M13-A,  showed that it 
contained an 862-bp open reading frame followed by 659 bp 
of 3' untranslated sequence, and was unlikely to encode full 
length M13. Therefore, a primer extended library was con- 
structed using neonatal rat brain RNA and a primer based 
on sequence 165 bp from the 5' end of M13-A.  The library 
was screened with a random-primer labeled probe generated 
from the 100 bp BglII fragment of M13-A (see Fig. 1), and 
52 positives were identified out of 9  x  104 plaques. Two of 
these,  M13PX-1 and M13PX-2,  were plaque purified and 
found to contain inserts of ,~1,200 and ~1,100 bp, respec- 
tively.  The combined length of M13-A and the overlapping 
M13PX-1  is  an  excellent match  for the  size  of the  M13 
mRNA observed in Northern analyses (see below), indicat- 
ing that together,  M13-A  and M13PX-1 constitute an es- 
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Figure  1.  HSPG  M13  cDNA  sequencing 
strategy.  The restriction sites used in sub- 
cloning and sequencing are indicated by let- 
ters: A, ApaI;  B, BgllI; E, EagI; K, KpnI; 
M, MspI; P, PstI; R, EcoRV;  S, SmaI; Sa, 
Sau3AI;  Sc,  SacI; Sp,  SphI;  and  T, TaqI. 
Arrows indicate individual sequencing  re- 
actions. The custom oligonucleotides used 
in sequencing are numbered. Oligonucleo- 
tide three was used as the primer in the con- 
struction  of  the  primer extended  library. 
The three M13 cDNAs are indicated  by the 
heavy lines below the restriction map. 
sentially full length M13  cDNA.  Fig.  1 illustrates  how the 
complete M13 cDNA sequence was obtained from M13-A, 
M13PX-2, and M13PX-1 by a combination of subcloning and 
the use of custom sequencing primers. 
Sequence Analysis 
The combined sequences of M13-A, M13PX-2, and M13PX- 
1 comprise a cDNA of 2,631 bp, shown in Fig. 2. The first 
ATG codon (at position 70), occurs in a poor context for ini- 
tiation of translation  (40), and the open reading frame that 
follows terminates after 240 bp. The second ATG codon (at 
position 236) occurs in a favorable context, with a G in the 
-3  position.  Beginning  with this codon,  an open reading 
frame  extends  1,740  bases  before  terminating  at  position 
1975.  An AATAAA cleavage and polyadenylation  signal is 
found at position 2582,  followed 13 bases later by a poly-A 
tract.  The deduced amino acid sequence of the long open 
reading frame correctly predicts the sequences of all four 
M13  tryptic peptides (underlined in Fig. 2),  including the 
three that were not used in screening the cDNA library. 
The deduced amino acid sequence features a stretch of hy- 
drophobic amino acids at both the amino and carboxy ter- 
mini,  which could serve as a signal  sequence and  a GPI- 
attachment  signal respectively.  HSPG M13  was previously 
shown to  be  GPI-linked  on  the  basis  of its  ability  to be 
released from Triton X-114 micelles by phosphatidylinositol 
specific-phospholipase C (30). With the removal of these sig- 
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191&  S  CAC  C  C  CGC,  GA~GACTA~C  CGG'/~T~GAGGT~  TCAGCTGAGGAAG  AA  CGC  CC  CACAACAG  CGGCAGGCAC  TAATC~CAC  CG  ~  CTC~ ~AG  C~A  t4)S 
A  P  R  E  E  T  S  R  S  W  R  S  S  A  E  E  E  R  P  T  T  A  A  G  T  N  L  H  R  L  V  W  E  L  R  E  R  L  S  8 
14~&  GTGCGGC~C  TTCTG~C T~GAC~YfCCCG~F~ACGGTGTG~CTCCCGCAT~GCC, GCAGATC%~  TCCCA~C~  ~CCC ~  C  ~~CC~TA~G  1555 
~s~v  R  G  F  W  A  G  L  P  V  T  V  ~  G__  D  S  ~  S  A  A  ,~)  L  $  Q  E  A  A  P  ~'~  W__  T  G  V  G  R  G  R  ¥  M  ~,~E 
155~ CCT~TGGTCGTGG~CT~CTTGAA~GCAGCTC~ATAACcCGGAGTTC~ATACTTCGAGTCCCGATGTCCC~CACG~C~AGGC~CA~AG~CT~G  I~95 
~P  V  V  V  O  S  L  N  E  Q  L  H  N  P  E  L  P  T  S  S  ~P O  V  P  T  R  ~  R  R  L  H  L  R  A  A  T  A  R  M  ~Ka 
~76  G  CGGCTGCGCTC~  CC  AC,  GAC  C~'I~A  CATGC  AT~AT~CGGA  T~AAGACG  C  CAGTC,  G  CTC  CGGAGGG  GGACAGCAGTACGCAGACGACTGGAAAGC~CA~GC  ~  ~C  CC  CA  :795 
A  A  A  L  G  Q  D  L  D  M  H  D  A  D  E  D  A  ~  G  G  Q  Q  Y  A  D  D  W  K  A  G  A  A  P  V  V  P  P 
179&  G  C  CAGG  CCTCCAAG  GC  CAC  CTCGTCCTC  CTCGAAGGGATGGTC  T~GAG  TGAGAGGAGGAAGTGGCAGTCCCAGATAC~C C  AG~ CCG~G CA~GTC~C  C  TC  ~I~ 
......  A  ~  p  ~  ~  P  P  ~  P  P  ~  ~  0  o  L  G  v  ~  G  G  S  G  S  A  R  Y  N  Q  G  ~  S  R  N~ L  S  S  S~ V  G  ~o 
~916 CATGCCCCACGTGTCTTCATTCTCCTCCCCTCAGCCCT~ACCCTGCTTGGACTTCGATAACAAGCGAGGGGCGC~CTAGCGTCAGGAGGCTTAGTGGCCTI`I~CTTCCACCTCCCT~AG  2335 
H  A  ?  R  V  F  ~  r.  L  P  s  A  [.  T  L  L  G  L  ~  " 
202~  C  ~G  CA'/~  AC4~AAGAI~T~  GAAC,  GGC,  G  CTAC  CGGGAGGG  CAGAAAC/~GA C~  TAG  GTAAA'I~  G  C'I~:~GC~C  CC  CAAATCCAGGAG'FI'?C CTA~  ~ ~~TAGA~  2~5 
2156  GGT~  'FI~2  ATAATAT'~-F~-~-~-~T-L  A%~GGAAC  TC,  GGGATA'FITATTTAGGAAC, GGATT~  TTCAG  CTC~G~ ~TCTCA~A~  C~CAG~G  2.'75 
2276  GATC  GGGT'/~GGAAC  "F~GT~GGAGGGG  '~ CACTATTGGCATC, GGCG  TAC  CTC.ATATT~C~T~CTAGC  ~A~G~A~AC  ~CC  ~ ~C  CARAT  "-395 
2396  TT~ GAGGC  ~AGGCAGGAGGA~CG~rGGA~AC  C  CATAAAATTAGGT~  CTGATAG  TGGAACAGGCGGGGTGGGAGGTA~ACC ~  AG~ AC~A~C  1515 
251~  TTAAATAT~GGGGA~CCCATCTT~T~ACC~CT~TCTAATGTTTCAGTGTTCACATCGGTGT~TA~GGT~T~C~ACCA~~  2~)I 
Figure  2.  Nucleotide  se- 
quence of HSPG M13  cDNA 
and  translation.  The  merged 
sequences of cDNAs MI3-A, 
M13PX-1,  and  M13PX-2  are 
given along with the deduced 
amino acid sequence of M13. 
Potential  glyeosaminoglycan 
attachment  sites  are  boxed. 
Cysteine residues are circled. 
Arrowheads indicate potential 
cleavage sites of the signal se- 
quence  (after Gly  2t)  and  the 
GPI  attachment  signal  se- 
quence (after Asn  ~3 or Ser557). 
(See text for discussion.) Se- 
quences  that correspond to 
M13 peptides (Table I) are un- 
derlined.  The  cerebroglycan 
cDNA sequence data are avail- 
able from G-enBank/EMBL un- 
der accession number L20468. 
The Journal of Cell Biology, Volume 124, 1994  152 nal  sequences,  the mature protein would have a  predicted 
molecular mass of 58.6-kD, in good agreement with the size 
of  the M13 core protein, as observed on reducing SDS-PAGE 
gels (57 kD) (30).  The protein contains seven "ser-gly" se- 
quences, five of which (boxed in Fig. 2) are potential GAG 
attachment sites (see Discussion).  No "N-X-S" or "N-X-T" 
N-linked glycosylation consensus  sequences are present. 
As  Fig.  3  illustrates,  the  M13  protein  sequence  shows 
significant homology to two other molecules,  rat glypican 
(37, 46), and the deduced protein sequence of OCI-5, a de- 
velopmentally regulated transcript cloned from a primitive 
intestinal  epithelial  rat  cell  line  (25).  The  homology  is 
moderate but extensive, with islands of highly conserved se- 
quence surrounded by divergent sequences. Most striking is 
the conservation of cysteine residues (heavy lines in Fig. 3): 
Of the 14 cysteines in the predicted sequence of the mature 
M13 protein, all are conserved in both glypican and OCI-5. 
In fact, the only cysteines in mature glypican and OCI-5 that 
are not found in M13 are a single pair near the COOH termi- 
nus. In addition, glypican and M13 share three putative ser- 
gly GAG attachment sites (Fig.  3, boxes), and one of these 
is  present  in  OCI-5 as  well.  M13  and  glypican are more 
closely related to each other, with an amino acid identity of 
37 %, than either M13 to OCI-5 or glypican to OCI-5, with 
20 % and 21%  identities,  respectively. 
Figure 4.  Southern  analysis. 
20  #g  of rat  genomic  DNA 
was  digested  to  completion 
with  one of three  restriction 
enzymes,  separated  by elec- 
trophoresis,  blotted  to  nitro- 
cellulose,  and  probed  with 
an  ~32P-dCTP-labeled  MI3 
probe. The sizes of  DNA stan- 
dards  are indicated.  The re- 
striction  enzymes  used  were 
HindlII (H),  KpnI (K),  and 
XhoI (X). 
Southern Hybridization 
To assess whether M13 is present as a single copy in the ge- 
nome, 10 #g of rat thymus DNA was digested to completion 
with HindlII, KpnI, or XhoI, separated by agarose gel elec- 
trophoresis, and transferred to nitrocellulose. The filter was 
probed with a random primer-labeled probe made from the 
100-bp BglII fragment of the M13-A eDNA. The resulting 
autoradiogram is shown in Fig. 4. In each lane a single band 
appears indicating that the gene encoding M13 is present as 
a  single copy in the rat genome. 
Developmental Expression 
M13 is observed in the membrane fraction of embryonic day 
18  (El8)  and newborn (P0) rat brain,  but not in the adult 
(30). To assess the expression of M13 mRNA, Northern blot 
analysis was performed using 20 #g of total RNA from each 
of these three developmental stages, and a random-primer- 
Figure 3. HSPG M13 is related to glypican and OCI-5. The protein 
sequence of HSPG M13 has been aligned with those of the GPI- 
linked HSPG, glypican, and the predicted protein product of OCI- 
5, a developmentally regulated transcript isolated from a rat primi- 
tive intestinal epithelial cell line (25). Solid lines indicate sequence 
identities, and dotted lines indicate conservative substitutions. The 
cysteine pattern of the three molecules is absolutely conserved as 
indicated by the heavy lines. Potential glycosaminoglycan attach- 
ment sites are boxed. 
Figure 5.  Northern  analysis. 
20 #g of rat brain total RNA 
isolated  from embryonic  day 
18 (E/8), newborn (P0), and 
adult (A) rats was subjected to 
electrophoresis through form- 
aldehyde  agarose  and  trans- 
ferred to nitrocellulose. A 2.7- 
kb  transcript  was  detected 
with  an  u32p-dCTP-labeled 
M13  probe.  (Lower  panel) 
Reprobing of the blot with a 
GAPDH probe demonstrated 
that a similar amount of RNA 
was present in each lane. The 
positions of molecular weight 
markers and ribosomal  RNA 
bands are indicated. 
Stipp et al. Cloning  and Expression of Cerebroglycan  153 labeled probe generated using cDNA M13-A as the template 
(Fig. 5). A single transcript of'x,  2.7 kb was seen that is rela- 
tively abundant at El8, less so at P0, and undetectable in the 
adult sample. The filter was re-probed with a glyceraldehyde- 
phosphate  dehydrogenase (GAPDH) probe (Fig.  5,  lower 
panel), demonstrating that there was not an appreciable dif- 
ference in the amount of RNA loaded in each lane. Thus, the 
developmental expression of M13  mRNA agrees with that 
previously observed for M13 protein (30). 
To localize M13 expression in the developing animal,  in 
situ hybridization was performed. The 306 bp SacI or the 
223 bp ApaI-KpnI pBluescript subclones of  the M13 cDNA, 
M13-A  (Fig.  1),  were used to generate ot3sS-UTP labeled 
RNA probes. Fig. 6 shows the results obtained when these 
probes  were  hybridized  to  fresh-frozen sections  of em- 
bryonic day 14 (El4), 16 (El6), and 19 (El9), and newborn 
(P0) animals. The results are presented as "reverse contrast" 
images,  printed directly from autoradiograms  of the  sec- 
tions. 
In El4 and El6 animals (Fig. 6, B and D) strong MI3 ex- 
pression  occurs  along  the  entire  neuraxis,  including  the 
brain,  spinal cord,  dorsal root ganglia,  and cranial nerve 
Figure 6. PG M13 expression in the developing nervous system. (A, C, E, and H) Cresyl violet stained sections. (B, D, F,, G, and I) reverse 
contrast images printed directly from autoradiograms of the same sections hybridized to ~3sS-UTP labeled, in vitro transcribed,  M13 
RNA probe. (A and B) embryonic day 14 whole embryo; (C and D) embryonic day 16 whole embryo; (E-G) embryonic day 19 whole 
embryo; (H and I) neonatal head. (s) spinal cord; (te) telencephalon; (cx)  cerebral cortex; (cb) cerebellar cortex; (d) dorsal root ganglia; 
(p) pontine nuclei; (i) inferior colliculus; (ob) olfactory bulb; (hi) hippoeampus; (sO striatum, (th) thalamus. G shows the result when 
a sense orientation (negative control) probe was hybridized to an adjacent section of the embryonic day 19 animal; the image was printed 
at high contrast to allow visualization of the faint background. Bar, 5 mm. 
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tected. By El9 (Fig. 6 F), expression in the spinal cord and 
dorsal root ganglia is dramatically lower than in the many 
regions of the brain that still express high levels of M13 mes- 
sage,  including the cerebral  cortex,  hippocarnpus,  corpus 
striaturn, inferior colliculus, and pontine nuclei. As at earlier 
stages,  hybridization to non-neural tissues was not above 
background. In the P0 head (Fig. 6 I), strong expression per- 
sists in the cerebral cortex, hippocampus, striatum, inferior 
colliculus, and cerebellar cortex, but only weak expression 
is seen elsewhere in the brain. Again, expression was not ob- 
served outside the nervous system. Fig. 6 G shows an exam- 
ple of the results obtained when the opposite strand control 
probe was hybridized to a nearly adjacent section (in this 
case, in the E19 animal). No hybridization above background 
was observed in any tissue. 
AS Fig. 6 illustrates, M13 is globally expressed in the ner- 
vous system at early stages. AS neural development proceeds 
expression is selectively lost from certain structures while 
remaining in others. A closer examination of the pattern of 
expression suggested that M13 mRNA remains in structures 
for several days after neurogenesis-the production of post- 
mitotic neurons-has ended (see Discussion).  This raised 
the possibility that M13 expression might be associated with 
neuronal precursors and/or immature neurons. 
To more accurately examine the relationship between M13 
expression and neuronal development, in situ hybridization 
was carried out using sections of postnatal day 7 (P7) brain. 
At this age, the generation and early development of neurons 
has finished in most of the brain, but persists in three late- 
developing areas: the external granule layer of the cerebel- 
lum, the dentate gyrus of  the hippocampus, and interneurons 
of the olfactory bulb (34).  As shown in Fig. 7, M13 is ex- 
pressed at this stage in precisely these three areas: the folia 
of  the cerebellum, the dentate gyrus of  the hippoeampus, and 
the olfactory bulb. As with the earlier experiments, no hy- 
bridization with the opposite-strand control probe was de- 
tected (not shown). 
A higher magnification view of the cerebellum (Fig. 8 A) 
reveals that M13-expressing cells are found in the external 
granule layer (EGL), the zone in which granule cells (cere- 
bellar interneurons) are generated and undergo initial stages 
(~28 h) of development (26).  In contrast, the internal gran- 
ule layer (IGL), which contains mature granule cells, was es- 
sentially devoid of hybridization. A  higher magnification 
view of the olfactory bulb (not shown) revealed that M13- 
expressing cells are localized to the subventricular zone, the 
site of postnatal production of olfactory bulb interneurons 
(granule cells and periglomerular cells) (48).  In contrast, 
layers containing mature olfactory bulb neurons were devoid 
of M13 hybridization (these layers lie anterior to the indi- 
cated region of hybridization in Fig. 7, and were visualized 
by Hoechst 33258  fluorescence) (not shown). 
These results suggest that, at least in these tissues, expres- 
sion of M13 is restricted to an early stage in the development 
of neurons. An indication of how early M13 appears can be 
obtained by examining the distribution of cells within the ex- 
ternal granule layer of the cerebellum. As shown in Fig. 8 
A, M13-expressing cells are strongly concentrated within the 
deeper  half of the  external  granule  layer,  the  so-called 
Figure 7. Expression of  HSPG M13 in postnatal rat brain. Darkfield  photomicrograph  of  a postnatal day 7 rat brain after in situ hybridization 
with an t~35S-UTP labeled M13 RNA probe. Hybridization is detected in the cerebellum (cb), the dentate gyrus of the hi--pus  (dg), 
and in migrating granule cell precursors of the olfactory bulb (arrow). No hybridization was detected with the sense orientation (negative 
control) probe (not shown). Bar, 1 mm. 
Stipp et al. Cloning and Expression of Cerebroglycan  155 Figure 8.  HSPG MI3 is expressed by postmitotic neurons. Simultaneous visualization of MI3 mRNA (darktield optics) and cell nuclei 
(Hoechst blue fluorescence). (A) I'7 cerebellum. Hybridization  is localized  to the external granule layer, and is concentrated in the premigra- 
tory zone, which contains newly postinitotic granule neurons. EGL, external granule layer; ML, molecular layer; IGL, internal granule 
layer; pz, proliferative zone; pmz, premigatory zone. (B) El2 spinal cord. Hybridization is detected in the forrnin~ dorsal horns (DH), 
and ventral horns (VH)  of the spinal cord, and the dorsal root ganglia (arrows),  but not the ventricular zone (VZ). The cleft in the ventricular 
zone of the spinal cord was an artifact  of sectioning. No signal was detected in adjacent sections hybridized  with sense orientation (negative 
control) probe (not shown). Bar,  100 #m. 
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ated, postmitotic neurons, whereas the superficial half of the 
external granule layer contains the proliferating cells that 
give rise to those neurons. This result indicates that M13 ex- 
pression begins in neurons at or about the time they become 
postmitotic. 
To further test this hypothesis, in situ hybridization was 
used to examine M13 expression in the embryonic day 12 
(El2) spinal cord. At this stage, the spinal cord consists of 
a large central proliferative zone (the ventricular zone), from 
which newly postmitotic neurons migrate laterally to form 
the nascent ventral and dorsal horns (3).  As Fig. 8 B illus- 
trates, M13 is strongly expressed by regions of the El2 spinal 
cord that contain postmitotic neurons, but weakly expressed, 
if at all,  by the still-proliferating neural precursors of the 
ventricular zone. In addition, expression can be seen in the 
dorsal root ganglia (DRG) located on either side of  the spinal 
cord.  These  structures  also  contain recently post-mitotic 
neurons (3), the progeny, in this case, of neural crest cells. 
These data suggest that M13 is specifically and transiently 
expressed by neurons during their immediate post-mitotic 
period. As discussed below, the window of expression of this 
molecule correlates particularly well, throughout the ner- 
vous system, with the time period during which neuronal 
migration and axon outgrowth take place. 
Discussion 
Molecular Cloning of Cerebroglycan 
Several lines of evidence confirm that the cDNA obtained in 
this study encodes the GPI-anchored HSPG core protein pre- 
viously designated as M13 (30): The cDNA encodes all four 
of the peptides that were obtained from a tryptic digest of 
M13; it encodes a protein of the correct size, which contains 
likely GPI anchorage and GAG-attachment sequences (see 
below); and it hybridizes to an rnRNA that is present in em- 
bryonic and neonatal rat brain, but not in adult brain (match- 
ing the pattern previously observed for M13 protein) (30). 
In situ hybridization demonstrated that, at every stage so far 
examined, expression ofHSPG M13 is limited to the nervous 
system. This result is surprising because no other proteogly- 
can is known to be restricted in expression to a single tissue. 
To reflect the nervous system-specific expression of this pro- 
teoglycan, we have chosen to name PG M13 "cerebroglyeanY 
Sequence Analysis 
The deduced amino acid sequence of cerebroglycan contains 
seven serine-glycine pairs,  representing possible GAG at- 
tachment sites.  Of these, set  ~55, ser  49s and ser  5°° all match 
the sequence SGXG, and all occur within regions of protein 
sequence that are rich in acidic residues. Both features have 
been proposed to define a consensus for GAG attachment (7, 
8).  In  addition,  two other serine-glycine pairs  (ser  55 and 
ser  02) occur either just before or just after an acidic residue, 
and might also represent GAG attachment sites (7). Interest- 
ingly, sel  "49s and ser  ~  were sequenceable residues of pep- 
tide M13-22.  Since substitution of serine with GAG chains 
should result in a blank cycle in Edman degradation, it is 
possible that these  sites  are  not actually substitu*ed  with 
GAG chains, or that only a fraction of cerebroglycan core 
proteins are substituted at both these sites. 
The cerebroglycan protein sequence has a stretch of  hydro- 
phobic amino acids at both the amino and carboxy termini, 
as indicated in Fig. 2. These sequences could serve as the 
signal sequence and a  GPI-attachment signal respectively, 
being cleaved off  in the mature protein. The precise cleavage 
sites are unknown, and those indicated in Fig. 2 are predic- 
tions based upon the  -1,-3  rule (72),  for the signal se- 
quence, and the ~o, w +  2 rule (39),  for the GPI-attachment 
signal. Of the two potential GPI-attachment sites indicated, 
ser  55~ has a slightly higher probability than ash  55~, based on 
amino acid preferences at the ~0 and o~ +2 sites of other GPI- 
anchored proteins. After the candidate GPI-attachment sites 
are a potential "hinge" region (rich in proline and charged 
amino acids), and a stretch of  hydrophobic amino acids; both 
the hinge and hydrophobic stretch are features of GPI attach- 
ment signals (39). 
Cerebroglycan Defines a Family of GPI-Anchored PGs 
The deduced amino acid sequence of cerebroglycan shares 
significant homology with two other molecules, the GPI- 
anchored HSPG glypican, and the predicted product of a de- 
velopmentally regulated transcript, OCI-5, that was cloned 
from a rat primitive intestinal epithelial cell line (Fig. 3). 
The most striking feature of the homology is the absolute 
conservation of 14 cysteine residues. It is likely that these 
residues are involved in stabilizing a highly compact tertiary 
structure, since both glypican and cerebroglycan exhibit ap- 
parent molecular masses on SDS-PAGE gels that are ~10 kD 
lower under nonreducing conditions than under reducing 
conditions (30).  A search of protein databases revealed no 
other molecules with a similar pattern of cysteines in their 
primary  structures.  Thus,  cerebroglycan,  glypican,  and 
OCI-5 apparently constitute a new family of proteins charac- 
terized by similar core protein size,  GPI linkage, the pres- 
ence of potential GAG attachment sites, and a unique cys- 
teine  pattern.  Since  the  protein  encoded  by  the  OCI-5 
transcript  has  yet to  be  purified,  it  remains  to  be  seen 
whether this molecule actually bears GAG chains in vivo. 
Of the four major transmembrane HSPGs that have been 
identified to date, all were recently classified into a single 
gene family, on the basis of homology with syndecan (7). 
The  data  presented  here  suggest  that  the  GPI-anchored 
HSPGs-which are also major PGs in many cells (10, 21, 33, 
77)-may also be classifiable into a single gene family. It is 
interesting  that members  of the  syndecan family exhibit 
significant sequence similarity only in their transmembrane 
and cytoplasmic domains, while their extracellular domains 
have diverged rapidly, even among orthologues in different 
mammalian species (7). These results have suggested that the 
extracellular domains of syndecans may serve no conserved 
function other than as a protein scaffold onto which GAG 
chains are attached. In contrast, the GPI-anchored HSPG 
family exhibits a high degree of sequence similarity among 
homologues, and appears to be evolving more slowly than 
the syndecans (e.g., rat and human glypican are 91% identi- 
cal in their mature protein sequences [37, 46], while the ex- 
tracellular domains of  mouse and human syndecan-1 are only 
70%  identical [7]). 
This analysis raises the possibility that the cerebroglycan, 
glypican, and OCI-5 polypeptides subserve functions other 
than just the anchorage of GAG chains to the cell surface. 
Stipp et al. Cloning and Expression of Cerebroglycan  157 For example, these core proteins might bind as yet unknown 
ligands. Other ligand-binding PG core proteins include the 
core proteins of betaglycan (which binds TGF-B) (12) and 
decorin (which binds to collagen fibrils) (41, 71). 
Alternatively, the conserved protein structure of the GPI- 
anchored  HSPGs  may  play  a  regulatory  role  in  post- 
translational processing. For example, the protein might in- 
teract with components of the Golgi apparatus in order to 
influence the type of GAG that it receives (e.g., HS versus 
chondroitin sulfate), or even the sequence of GAG modifica- 
tions (e.g., sulfation) that is subsequently generated. Recent 
studies  underscore  the  importance  of differences in  GAG 
modification  on  the  biological  properties  of HSPGs  (51, 
61, 63). 
Cerebroglycan Expression Marks a Distinct Stage in 
Neuronal Development 
Examination  of patterns of cerebroglycan message expres- 
sion  by  in  situ  hybridization  suggests  that  cerebroglycan 
rnRNA (a) is produced by neurons, (b) appears at around the 
time of a neuron'g terminal mitosis, and (c) disappears by the 
time that neuronal migration and axonal extension have been 
completed. 
Strong support for this interpretation comes from exami- 
nation  of the  developing  cerebellum,  in  which  neuronal 
birth, migration and maturation occur in distinct anatomical 
layers (66). In that structure, cells that proliferate in the su- 
perficial part of the external granule layer give rise to post- 
mitotic neurons that reside in the deep part of the same layer, 
and these in turn migrate rapidly through the molecular layer 
to reach their final positions in the internal granule layer. The 
concentration of cerebroglycan mRNA in the deep half of the 
external granule layer (Fig. 8 A) implies that cerebroglycan 
begins to be expressed at or after final mitosis, while its ab- 
sence from the internal granule layer implies that cerebro- 
glycan message disappears by the time cell body migration 
has finished.  From studies of the timing of cerebeUar neu- 
ron migration (26), it can be concluded that the window of 
cerebroglycan mRNA expression in granule cells is "~36 h 
or less. 
The view that cerebroglycan is first expressed when neu- 
rons become postmitotic is supported by results in the early 
spinal cord, in which mRNA is found only in regions con- 
taining newly generated neurons (Fig. 8 B), and by the fact 
that all sites of cerebroglycan mRNA expression throughout 
the nervous system contain neurons that have been generated 
within the preceding 2-3 d  (e.g., EI2-E16 spinal cord and 
DRG [Figs. 6 and 8; ref. 3]; E14-P0 cerebral cortex [Fig. 6; 
ref. 6]; E19-P0 inferior colliculus [Fig. 6; ref. 2]; El9 pon- 
tine nuclei [Fig. 6; ref.  1]; El8 retina [not shown; ref. 79]; 
and P7 hippocampus and olfactory bulb [Fig. 7; refs. 4, 5]). 
In contrast, little if any cerebroglycan mRNA is found in the 
proliferating  neural  precursors  that  form  the  ventricular 
zone, both in the El2 spinal cord (Fig. 8 B) and throughout 
the developing brain (not shown). 
The time of disappearance of cerebroglycan message in at 
least one structure other than the cerebellum also correlates 
with  completion  of neuronal  migration:  cells  expressing 
cerebroglycan are found in the subventricular zone pathway 
along which olfactory bulb interneuron precursors migrate 
(48), but not in the layers of the olfactory bulb that contain 
interneurons  that have completed their migration.  In other 
parts of the nervous system, however, a simple correlation 
between cerebroglycan expression and neuronal  cell body 
migration cannot be drawn.  The ventral horn of the spinal 
cord,  the  dorsal  root ganglia,  the  El9  thalamus,  the  su- 
perficial layers of the El9 and P0 cerebral cortex, and the 
dentate gyrus of the hippocampus (Figs. 6-8), all primarily 
consist of neurons that have reached their final positions, yet 
express cerebroglycan. Interestingly, although the cell bod- 
ies of these neurons are not migrating at these times, their 
axons are generally still growing. If the same ceils are exam- 
ined after their axons have reached target areas, cerebrogly- 
can message is undetectable (e.g.,  after E20 for thalamus 
[22]; El8 for dorsal root ganglia [38]; and P2-P5 for cerebral 
cortex [52]). Since axon growth and cell migration are both 
forms of cell motility  (9,  18),  the data  suggest a  general 
correlation between cerebroglycan expression and periods of 
time during which neurons engage in motile behaviors. 
Although the data presented cannot rule out the possibility 
that some glial cells transiently express cerebroglycan, nei- 
ther the timing  nor pattern of expression of cerebroglycan 
match the timing or sites of glial production in the brain, 
which is largely postnatal  (34).  In addition,  several of the 
structures  in  the  developing  brain  that  highly  express 
cerebroglycan mRNA contain  few if any glial cell bodies, 
e.g., the external granule layer of the cerebellum (Fig. 8) and 
the El8  retina  (data not shown).  Interestingly,  recent evi- 
dence indicates that, in the adult rat brain, glypican is also 
expressed largely, if not exclusively, by neurons  (46). 
Possible Roles for Cerebroglycan in the Developing 
Nervous System 
If cerebroglycan is expressed by neurons specifically at times 
of cell migration and axon pathfinding, it raises the possibil- 
ity that cerebroglycan plays a role in these events. Many of 
the molecules that have been implicated  in the control of 
these cell behaviors-including  extracellular matrix glyco- 
proteins, polypcptide growth factors, and cell-cell adhesion 
molecules-share a common feature: they bind GAGs, espe- 
cially HS and the related GAG heparin (42). The abundance 
(30) and pattern of expression of cerebroglycan in the de- 
veloping nervous system suggest that it could play an impor- 
tant role in the recognition of these classes of molecules. 
For example, axons that leave the cerebral cortex navigate 
within a layer that contains both fibronectin (65) and laminin 
(32),  two extracellular  matrix  proteins  that promote axon 
growth in vitro. Both of these proteins bind HSPGs, and re- 
cent studies suggest that cell surface HSPGs are essential for 
the interactions of central nervous system neurons with fibro- 
nectin (29). Importantly, expression of cerebroglycan in the 
cerebral cortex occurs during the major period of cortical 
axon growth through this region (20). Laminin is also present 
along pathways followed by retinal axons (15, 50), as well as 
those followed by the peripheral axons of spinal motoneurons 
and dorsal root ganglion neurons (56). In each case, we now 
know that these pathways are navigated by neurons that, at 
the time, express cerebroglycan mRNA. Moreover, if the cel- 
lular distribution of cerebroglycan is similar to that of other 
GPI-anchored proteins expressed by neurons, this HSPG is 
likely to be found on the surface of axons (e.g., 24, 27, 76). 
Other potential ligands for cerebroglycan in the develop- 
ing  nervous  system  include  the  cell  adhesion  molecule 
NCAM-which  appears  to  require  an  interaction  with 
The Journal of Cell Biology, Volume  124, 1994  158 HSPGs for at least some of its functions (16, 55)-and hepa- 
fin binding growth factors such as FGF-1, FGF-2, and FGF- 
5, which are known to influence neuronal survival and neu- 
rite outgrowth in vitro (31, 70, 73, 74), and which apparently 
require HSPGs to interact with cells  (54,  78). 
The fact that cerebroglycan  is a GPI-anchored molecule 
also  raises  the  possibility  that  the  binding  of ligands  to 
cerebroglycan could lead to the production of intraceUular 
signals.  Crosslinking  of  any  of  a  wide  variety  of  GPI- 
anchored proteins on the surface of leukocytes is known to 
trigger changes in intracellular calcium levels, protein secre- 
tion and cell proliferation (47, 53). The mechanism of GPI- 
mediated signal transduction has not been determined,  but 
may involve the interaction of GPI-anchored proteins with 
transmembrane proteins such as tyrosine kinases (69), or the 
phospholipase-induced cleavage of the GPI-anchor, followed 
by rebinding of the anchor to a specific  signal-transducing 
receptor (59). Future studies aimed at determining precisely 
which molecules cerebroglycan interacts with, and what the 
intracellular consequences of those interactions are, will be 
critical  in defining the in vivo functions of this molecule. 
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